歌礼制药-B(01672)宣布口服小分子GLP-1R激动剂ASC30治疗糖尿病的13周美国II期研究完成首批受试者给药
Last Update:
26 1 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.